Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA’s Latest PR Push: Protecting the Reputation of Generic Drugs

09 Apr 2012

• By Kate Rawson

Related Content

To Prevent Drug Shortages, Don't Look To Inspections, FDA Says

22 Aug 2011

FDA Aims To Bolster Generics' Image With Research, Regulatory Changes

16 Nov 2009

ANDA User Fees Will Fund Public Relations-focused Studies On Palatability Of Generics

12 Dec 2011

Drug Shortages Endgame: FDA Goes On Offensive As Legislative Plot Thickens

19 Mar 2012

Drug Shortage Provisions In Draft PDUFA Bill Would Expedite Major Manufacturing Changes

19 Mar 2012

FDA's Woodcock Expresses Concern Not All Generics Are Equivalent, But OGD May Have Solution

01 Nov 2010

FDA’s Drug Shortage Reg Adds More Manufacturers, Products To Notification List

19 Dec 2011

Teva’s Generic Bupropion XL Meets Bioequivalence To Wellbutrin XL, FDA Finds

16 Apr 2008

Related Companies

Pfizer Inc.

AstraZeneca PLC

Novartis AG

Bristol Myers Squibb Company

Sanofi

Johnson & Johnson

UCB S.A.

Johnson & Johnson

Teva Pharmaceutical Industries Ltd.

GSK plc

Additional Topics

Manufacturing Quality Recalls BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.